FK614 is an orally active, non-thiazolidinedione (TZD) type, and selective PPARgamma modulator (SPPARM). FK614 functions as a PPARgamma agonist with potent anti-diabetic activity in vivo. FK614 has different effects on the activation of PPARgamma at each stage of adipocyte differentiation. FK614 can be used for the research of hyperglycemia, hypertriglyceridemia, glucose intolerance and type 2 diabetes[1][2].
Molecular Weight:
468.40
Purity:
99.97
CAS Number:
[193012-35-0]
Formula:
C21H23Cl2N3O3S
Target:
PPAR
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
